Lista de obras - David Kendler - Dominio Público Uruguay

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

artículo científico publicado en 2005

A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density

artículo científico publicado en 2012

A review of strontium ranelate and its effect on DXA scans

artículo científico publicado en 2007

Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international

artículo científico publicado en 2006

Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium

artículo científico

Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond

artículo científico publicado en 2009

Bisphosphonate associated osteonecrosis of the jaw.

artículo científico publicado en 2009

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday

artículo científico publicado en 2012

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab

scientific article published on 18 October 2019

Bone strength: the whole is greater than the sum of its parts

artículo científico publicado en 2006

Boning up on osteoporosis--current thinking on management. Interview by Emma Buchanan.

artículo científico publicado en 2006

Build better bones with exercise: protocol for a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in women with a vertebral fracture

artículo científico publicado en 2014

Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.

artículo científico publicado en 2008

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass

artículo científico

Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis.

artículo científico publicado en 2012

Diagnosis and management of vertebral fractures in elderly adults

artículo científico publicado en 2002

Diagnosis and treatment of Paget's disease of bone

artículo científico publicado en 2007

Dual-Energy X-Ray Absorptiometry Technical issues: the 2007 ISCD Official Positions

artículo científico publicado en 2008

Effect of alendronate and vitamin D3 on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women

article

Effect of calcium tablets on interpretation of lumbar spine DXA scans

artículo científico publicado en 2006

Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial

artículo científico publicado en 2009

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

artículo científico publicado en 2008

Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies.

artículo científico publicado en 2010

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women

artículo científico publicado en 2008

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy.

artículo científico publicado en 2010

Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass

artículo científico publicado en 2011

Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis

artículo científico publicado en 2009

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study

artículo científico publicado en 2010

Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial

artículo científico publicado en 2020

Femoral fractures in osteoporotic patients on bisphosphonates. A case report

artículo científico publicado en 2012

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women ⬇️

artículo científico publicado el 17 de septiembre de 2011

High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group.

artículo científico publicado en 2013

Implementation of osteoporosis screening guidelines in prostate cancer patients on androgen ablation

artículo científico publicado en 2009

Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction study

artículo científico publicado en 2014

Intake of calcium and vitamin D in 3 Canadian long-term care facilities

artículo científico publicado en 2002

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

artículo científico publicado en 2008

International Society for Clinical Densitometry official positions: Asia-Pacific Region consensus

scientific article published on 21 July 2010

Lasofoxifene in postmenopausal women with osteoporosis

artículo científico publicado en 2010

MIA is a potential biomarker for tumour load in neurofibromatosis type 1

artículo científico publicado en 2011

Management of osteoporosis in men: an update and case example

artículo científico publicado en 2007

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

artículo científico publicado en 2005

Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib

artículo científico publicado en 2011

North American male reference population for speed of sound in bone at multiple skeletal sites

artículo científico publicado en 2002

Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

artículo científico publicado en 2011

Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference

artículo científico publicado en 2008

Official positions of the International Society for Clinical Densitometry

scientific article published on 18 August 2006

Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference

artículo científico publicado en 2006

Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment

artículo científico publicado en 2004

Osteoporosis: therapies now and in the future.

artículo científico publicado en 2011

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

artículo científico publicado en 2005

Patients with osteoporosis prefer once weekly to once daily dosing with alendronate

artículo científico publicado en 2004

Persistence and adherence to parenteral osteoporosis therapies: a systematic review

artículo científico publicado en 2020

Position Development Conference of the International Society for Clinical Densitometry. Vancouver, BC, July 15-17, 2005.

artículo científico publicado en 2006

Preventing fractures in postmenopausal women: how to assess risk

artículo científico publicado en 2011

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.

artículo científico publicado en 2012

Report of the International Society for Clinical Densitometry 2007 Adult Position Development Conference and Official Positions

artículo científico publicado en 2008

Role of exercise and nutrition status on bone mineral density in cystic fibrosis

artículo científico publicado en 2003

Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options

artículo científico publicado en 2009

Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial

artículo científico publicado en 2012

Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children

artículo científico publicado en 2004

Standards and guidelines for technologists performing central dual-energy X-ray absorptiometry.

artículo científico publicado en 2007

Standards for performing DXA in individuals with secondary causes of osteoporosis

artículo científico publicado en 2006

Strontium ranelate--data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action

artículo científico publicado en 2006

Summary of the International Society For Clinical Densitometry 2005 Position Development Conference

artículo científico publicado en 2007

The 2002 Canadian bone densitometry recommendations: take-home messages.

artículo científico publicado en 2002

The Official Positions of the International Society for Clinical Densitometry: Indications of Use and Reporting of DXA for Body Composition

artículo científico publicado en 2013

The association between trunk muscle endurance, balance and falls self-efficacy in women with osteoporotic vertebral fractures: an exploratory analysis from a pilot randomized controlled trial

scientific article published on 01 December 2019

The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future

artículo científico publicado en 2006

The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study

artículo científico publicado en 2013

Use of lowest single lumbar spine vertebra bone mineral density T-score and other T-score approaches for diagnosing osteoporosis and relationships with vertebral fracture status

artículo científico publicado en 2008

Lista de obras de David Kendler

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density

A review of strontium ranelate and its effect on DXA scans

Alendronic acid produces greater effects than risedronic acid on bone density and turnover in postmenopausal women with osteoporosis : results of FACTS -international

Approaches to treating NF1 tibial pseudarthrosis: consensus from the Children's Tumor Foundation NF1 Bone Abnormalities Consortium

Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond

Bisphosphonate associated osteonecrosis of the jaw.

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab

Bone strength: the whole is greater than the sum of its parts

Boning up on osteoporosis--current thinking on management. Interview by Emma Buchanan.

Build better bones with exercise: protocol for a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in women with a vertebral fracture

Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.

Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass

Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis.

Diagnosis and management of vertebral fractures in elderly adults

Diagnosis and treatment of Paget's disease of bone

Dual-Energy X-Ray Absorptiometry Technical issues: the 2007 ISCD Official Positions

Effect of alendronate and vitamin D3 on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women

Effect of calcium tablets on interpretation of lumbar spine DXA scans

Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies.

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy.

Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass

Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study

Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial

Femoral fractures in osteoporotic patients on bisphosphonates. A case report

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women ⬇️

High-resolution peripheral quantitative computed tomography for the assessment of bone strength and structure: a review by the Canadian Bone Strength Working Group.

Implementation of osteoporosis screening guidelines in prostate cancer patients on androgen ablation

Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction study

Intake of calcium and vitamin D in 3 Canadian long-term care facilities

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions

International Society for Clinical Densitometry official positions: Asia-Pacific Region consensus

Lasofoxifene in postmenopausal women with osteoporosis

MIA is a potential biomarker for tumour load in neurofibromatosis type 1

Management of osteoporosis in men: an update and case example

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib

North American male reference population for speed of sound in bone at multiple skeletal sites

Official Positions for FRAX® Bone Mineral Density and FRAX® simplification from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference

Official positions of the International Society for Clinical Densitometry

Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference

Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment

Osteoporosis: therapies now and in the future.

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

Patients with osteoporosis prefer once weekly to once daily dosing with alendronate

Persistence and adherence to parenteral osteoporosis therapies: a systematic review

Position Development Conference of the International Society for Clinical Densitometry. Vancouver, BC, July 15-17, 2005.

Preventing fractures in postmenopausal women: how to assess risk

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.

Report of the International Society for Clinical Densitometry 2007 Adult Position Development Conference and Official Positions

Role of exercise and nutrition status on bone mineral density in cystic fibrosis

Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options

Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial

Standards and guidelines for performing central dual-energy x-ray absorptiometry in premenopausal women, men, and children

Standards and guidelines for technologists performing central dual-energy X-ray absorptiometry.

Standards for performing DXA in individuals with secondary causes of osteoporosis

Strontium ranelate--data on vertebral and nonvertebral fracture efficacy and safety: mechanism of action

Summary of the International Society For Clinical Densitometry 2005 Position Development Conference

The 2002 Canadian bone densitometry recommendations: take-home messages.

The Official Positions of the International Society for Clinical Densitometry: Indications of Use and Reporting of DXA for Body Composition

The association between trunk muscle endurance, balance and falls self-efficacy in women with osteoporotic vertebral fractures: an exploratory analysis from a pilot randomized controlled trial

The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future

The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case-control study

Use of lowest single lumbar spine vertebra bone mineral density T-score and other T-score approaches for diagnosing osteoporosis and relationships with vertebral fracture status